Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rational polypharmacy in the bipolar affective disorders

R M Post1, T A Ketter, P J Pazzaglia

  • 1Biological Psychiatry Branch, NIMH, Bethesda, MD 20892-1272, USA.

Epilepsy Research. Supplement
|January 1, 1996
PubMed
Summary

Bipolar disorder often requires multiple medications beyond lithium. Anticonvulsants like carbamazepine and valproate show promise as effective adjuncts or alternatives, improving treatment outcomes for difficult-to-treat patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resurging measles in Armenia: unravelling challenges, implementing solutions.

Public health·2024
Same author

Microdermabrasion facilitates direct current stimulation by lowering skin resistance.

Skin health and disease·2022
Same author

Anatomical and fMRI-network comparison of multiple DLPFC targeting strategies for repetitive transcranial magnetic stimulation treatment of depression.

Brain stimulation·2021
Same author

Targeting location relates to treatment response in active but not sham rTMS stimulation.

Brain stimulation·2021
Same author

Reply.

AJNR. American journal of neuroradiology·2020
Same author

<i>Reply</i>.

AJNR. American journal of neuroradiology·2020

Area of Science:

  • Psychiatry
  • Pharmacology
  • Neuroscience

Background:

  • Bipolar disorder is complex, with many patients inadequately responding to lithium monotherapy.
  • Traditional adjunctive treatments (antidepressants, antipsychotics) carry significant risks, including mania induction, cycle acceleration, and tardive dyskinesia.
  • Specific patient subgroups, such as those with rapid cycling or co-occurring substance abuse, show poor lithium responsiveness.

Purpose of the Study:

  • To explore the efficacy of anticonvulsants as alternatives or adjuncts to lithium in bipolar disorder treatment.
  • To evaluate the use of carbamazepine and valproate in managing acute episodes and long-term prophylaxis.
  • To provide a rational polypharmacy approach for treatment-resistant bipolar disorder.

Main Methods:

Related Experiment Videos

  • Review of clinical evidence and treatment strategies for bipolar disorder.
  • Focus on the role of anticonvulsants (carbamazepine, valproate) and benzodiazepines (clonazepam, lorazepam).
  • Emphasis on sequential clinical trials and life chart methodology for personalized treatment.

    • Main Results:

    • Anticonvulsants carbamazepine and valproate are effective alternatives or adjuncts to lithium.
    • Adjunctive use of anticonvulsants with lithium can establish mood stabilization and improve acute episode management.
    • Combination therapy, including antidepressants like bupropion or SSRIs, may be necessary for depressive breakthroughs.

    Conclusions:

    • Anticonvulsants represent a valuable therapeutic option for bipolar disorder, particularly for lithium-nonresponsive patients.
    • A conservative, rational polypharmacy approach, guided by careful patient history and sequential trials, is crucial.
    • Optimizing pharmacodynamic and pharmacokinetic profiles while minimizing side effects is key to successful long-term management.